Calcium channel blockers and hypertension
G Tocci, A Battistoni, J Passerini… - Journal of …, 2015 - journals.sagepub.com
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the
burden of hypertension-related cardiovascular and renal diseases. In spite of these well …
burden of hypertension-related cardiovascular and renal diseases. In spite of these well …
The pharmacological properties of lipophilic calcium antagonists
PA VAN ZWIETEN - Blood pressure, 1998 - Taylor & Francis
Several types of calcium antagonists (CA)(verapamil, diltiazem, nifedipine and related
drugs) may be used as antihypertensives. In practice, the dihydropyridines (nifedipine and …
drugs) may be used as antihypertensives. In practice, the dihydropyridines (nifedipine and …
Lacidipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension
C Rhoda Lee, HM Bryson - Drugs, 1994 - Springer
Synopsis Lacidipine is an orally administered calcium channel blocker of the
dihydropyridine class, which shows selectivity for vascular smooth muscle over cardiac …
dihydropyridine class, which shows selectivity for vascular smooth muscle over cardiac …
Lacidipine: a review of its use in the management of hypertension
PL McCormack, AJ Wagstaff - Drugs, 2003 - Springer
Summary Abstract Lacidipine (Caldine®, Lacimen®, Lacipil®, Midotens®, Motens®) is a
once-daily, orally-administered, lipophilic dihydropyridine calcium antagonist with an …
once-daily, orally-administered, lipophilic dihydropyridine calcium antagonist with an …
Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines
RJM De Vries, DJ Van Veldhuisen… - American heart …, 2000 - Elsevier
Background Chronic heart failure (CHF) has high morbidity and mortality rates despite
treatment with angiotensin-converting enzyme inhibitors, diuretics, and digoxin. Adjunctive …
treatment with angiotensin-converting enzyme inhibitors, diuretics, and digoxin. Adjunctive …
1, 4‐dihydropyridine calcium channel ligands: Selectivity of action. The roles of pharmacokinetics, state‐dependent interactions, channel isoforms, and other factors
DJ Triggle - Drug development research, 2003 - Wiley Online Library
The selectivity of action of the clinically available calcium channel antagonists depends on a
number of factors: 1) Mode of calcium mobilization—intracellular and extracellular sources …
number of factors: 1) Mode of calcium mobilization—intracellular and extracellular sources …
How to improve effectiveness and adherence to antihypertensive drug therapy: central role of dihydropyridinic calcium channel blockers in hypertension
Essential hypertension is a complex clinical condition, characterized by multiple and
concomitant abnormal activation of different regulatory and contra-regulatory …
concomitant abnormal activation of different regulatory and contra-regulatory …
[HTML][HTML] Extreme bradycardia due to multiple drug–drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir–ritonavir
R Puech, MC Gagnieu, C Planus… - British journal of …, 2011 - ncbi.nlm.nih.gov
A 51-year-old man with a history of hypertensive and ischaemic myocardiopathy (cardiac
infarction 11 years ago), osteoarthritis and hypothyroidism, was treated daily with lacidipine …
infarction 11 years ago), osteoarthritis and hypothyroidism, was treated daily with lacidipine …
[图书][B] Hagers Handbuch der Pharmazeutischen Praxis: Drogen E—O
H Hager, S Greiner, G Heubl, E Stahl-Biskup - 2013 - books.google.com
Der zweite Band des Gebietes Drogen der Neuauflage enthält in alphabetischer
Reihenfolge von EO Monographien über Arzneipflanzengattungen. Jede Monographie …
Reihenfolge von EO Monographien über Arzneipflanzengattungen. Jede Monographie …
[HTML][HTML] Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs
B Yang, C Wu, B Ji, M Wu, Z He, L Shang… - asian journal of …, 2017 - Elsevier
The aim of the present study was to investigate virtual population pharmacokinetic using
physiologically based pharmacokinetic (PBPK) model for evaluating bioequivalence of oral …
physiologically based pharmacokinetic (PBPK) model for evaluating bioequivalence of oral …